PUBLIC SUBMISSION | As of: February 09, 2009 Tracking No. 806dd0ea Comments Due: August 29, 2008 |
Docket: CMS-2008-0073
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E Prescribing Exemption for Computer Generated Facsimile Transmissions
Comment On: CMS-2008-0073-0002
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule
Document: CMS-2008-0073-0534
Wolcott, Randall--PE
TX,
Endovenous ablation therapy has reduced the number of recalcitrant wounds that
we treat. The ability of endovenous ablation therapy to get these long chronic
wounds healed and more importantly to prevent recurrence has relieved much
suffering and reduced the overall cost to third party payers. Reducing
reimbursment for endovenous ablation therapy is shortsighted, whereas it will
reduce some up front cost it will create much more cost caring for unhealed
wounds. These costs include antibiotics, hospitalization and ongoing wound care
(not to mention ongoing patient suffering).